Aptargroup, Inc.
http://www.aptar.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Aptargroup, Inc.
Lupin-Aptar Launch India’s First Smart Device For MDIs At $22 Apiece
As the Indian pharma industry catches up with digitization, Lupin partners with Aptar to launch a smart device for MDIs. While there is a need for the product, whether it will find favor in a price-sensitive market remains to be seen.
Venture Funding Deals: Tenaya's $92m, Nuvation's $275m Lead October Rounds
Former Medivation CEO David Hung launched stealthy oncology start-up Nuvation with $275m in series A venture capital, while Tenaya's series B brought in $92m for small molecules as well as cell and gene therapies to treat cardiovascular diseases.
Pacts In Medtech: BI, Inflammasome Work On Retinal Disease; Takeda And Prometheus Take On IBD
Derived from Strategic Transactions, Informa's premium source for tracking life-sciences deals, the bimonthly Pacts In Medtech feature highlights notable technology alliances, research and development partnerships and commercial collaborations. This edition covers industry pacts that were signed in September and October 2019.
Keeping Track: US FDA Clears Two More Biosimilars, First Non-Injectable Glucagon
The latest drug development news and highlights from our US FDA Performance Tracker.
Company Information
- Industry
- Contract Research Organization-CRO
- Medical Devices
- Services
-
Pharmaceuticals
- OTC, Consumer
-
Drug Delivery
- Nasal
- Pulmonary
- Topical Delivery
- Other Names / Subsidiaries
-
- Aptar pharma
- Noble International, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice